Ledger.Open graph →
SEC Form D · filed March 21, 2017

Spero Therapeutics, LLC

Offering
$43.2M
Sold
$43.2M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Patrick Vink · Cambridge, MADirectorMilind Deshpande · Cambridge, MADirectorCasper Breum · Helsinki, H9DirectorAnkit Mahadevia · Cambridge, MAExec · DirectorJean-Francois Formela · Broomfield, CODirectorReza Halse · Cambridge, MADirectorStephen Garbacz · Cambridge, MAExecVikas Goyal · Cambridge, MADirectorPatrick Vink · Cambridge, MADirectorMilind Deshpande · Cambridge, MADirectorJean-Francois Formela · Cambridge, MADirectorReza Halse · Cambridge, MADirectorCasper Breum · Helsinki, H9DirectorAnkit Mahadevia · Cambridge, MAExec · DirectorStephen Garbacz · Cambridge, MAExecVikas Goyal · Cambridge, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗